Anthony J Olszanski

13PUBLICATIONS
85CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSolid tumoursTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 24, 2025
A First-In-Human Study of the SUMOylation Inhibitor Subasumstat in Patients with Advanced/Metastatic Solid Tumors or Relapsed/Refractory Hematologic Malignancies.

Dejan Juric, Daniel Anderson, Afshin Dowlati

|Feb 13, 2025
Recurrent Melanoma in a Patient with Chronic Lymphocytic Leukemia (CLL) Presenting with an Apparent Co-Existing NRAS and BRAF Mutation: A Diagnostic and Treatment Conundrum.

Giuliana G Berardi, Jabbar Muthanna, Y Lynn Wang

|Aug 08, 2023
Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies.

Diana Restifo, Joseph R McDermott, Dusica Cvetkovic

|Mar 31, 2023
SALVO: Single-Arm Trial of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma.

Lisa A Kottschade, Gregory Russell Pond, Anthony J Olszanski

|Jan 25, 2023
Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer.

Giuseppe Curigliano, Geoffrey I Shapiro, Rebecca S Kristeleit

|Jan 09, 2023
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial.

David S Hong, Brian A Van Tine, Swethajit Biswas

Pageof 3

Frequent Collaborators

2 joint publications

Annick Seithel-Keuth

2 joint publications

Geoffrey I Shapiro

2 joint publications

Jordan Berlin

2 joint publications

Maria Alsina